The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus

Publicado en línea: 08 may 2020

Páginas: 137 - 155

DOI: https://doi.org/10.2478/enr-2020-0017

Palabras clave

cinnamic acids and related compounds, type 2 diabetes mellitus, central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation and inflammation

© 2020 Douglas Edward Barre et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.